ProShare Advisors LLC - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 93 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$62,000
-56.6%
12,344
+9.4%
0.00%
-100.0%
Q4 2020$143,000
+15.3%
11,282
+9.5%
0.00%0.0%
Q1 2019$124,000
-3.1%
10,307
+1.3%
0.00%0.0%
Q4 2018$128,000
-28.9%
10,171
-16.3%
0.00%0.0%
Q3 2018$180,000
-15.5%
12,153
-3.8%
0.00%0.0%
Q2 2018$213,000
-27.6%
12,635
-1.4%
0.00%
-50.0%
Q1 2018$294,000
-23.8%
12,820
-14.1%
0.00%
-33.3%
Q4 2017$386,000
+144.3%
14,931
-4.6%
0.00%
+50.0%
Q3 2016$158,000
-24.0%
15,648
-15.7%
0.00%
-33.3%
Q2 2016$208,000
-16.5%
18,558
+1.8%
0.00%0.0%
Q1 2016$249,000
-34.3%
18,232
-8.8%
0.00%
-40.0%
Q4 2015$379,000
+11.1%
19,998
+9.9%
0.01%0.0%
Q3 2015$341,000
+18.8%
18,189
-5.7%
0.01%
+25.0%
Q2 2015$287,000
+29.3%
19,296
+31.7%
0.00%
+33.3%
Q1 2015$222,000
+38.8%
14,653
+21.7%
0.00%
+50.0%
Q4 2014$160,00012,0440.00%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
L1 Capital Pty Ltd 1,149,120$14,559,0002.72%
Corriente Advisors, LLC 680,000$8,595,0002.05%
ACUTA CAPITAL PARTNERS, LLC 537,500$6,794,0001.85%
INGALLS & SNYDER LLC 1,362,203$17,218,0000.85%
Kensington Investment Counsel, LLC 75,533$955,0000.79%
SPHERA FUNDS MANAGEMENT LTD. 384,039$4,854,0000.43%
Opaleye Management Inc. 254,000$3,211,0000.42%
RA Capital Management 1,823,520$23,049,0000.32%
Perceptive Advisors 2,150,641$27,184,0000.29%
Parkman Healthcare Partners LLC 50,290$636,0000.16%
View complete list of CONCERT PHARMACEUTICALS INC shareholders